Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 200132-54-3 | MDL No. : | MFCD01632446 |
Formula : | C37H37BrN2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | - |
M.W : | 605.61 | Pubchem ID : | - |
Synonyms : |
|
Num. heavy atoms : | 41 |
Num. arom. heavy atoms : | 24 |
Fraction Csp3 : | 0.27 |
Num. rotatable bonds : | 8 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 181.24 |
TPSA : | 26.61 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -3.38 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 9.32 |
Log Po/w (WLOGP) : | 4.01 |
Log Po/w (MLOGP) : | 5.78 |
Log Po/w (SILICOS-IT) : | 8.12 |
Consensus Log Po/w : | 5.45 |
Lipinski : | 2.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.17 |
Log S (ESOL) : | -9.37 |
Solubility : | 0.000000257 mg/ml ; 0.0000000004 mol/l |
Class : | Poorly soluble |
Log S (Ali) : | -9.78 |
Solubility : | 0.0000001 mg/ml ; 0.0000000002 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -11.08 |
Solubility : | 0.000000005 mg/ml ; 0.0 mol/l |
Class : | Insoluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 3.0 |
Synthetic accessibility : | 6.03 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 69257-04-1 ]
(2S,4S,5R)-1-Benzyl-2-((R)-hydroxy(quinolin-4-yl)methyl)-5-vinylquinuclidin-1-ium chloride
Similarity: 0.86
[ 201594-84-5 ]
(S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine
Similarity: 0.66
[ 122368-54-1 ]
2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine
Similarity: 0.66
[ 356790-44-8 ]
(R)-(1-Benzylpyrrolidin-2-yl)diphenylmethanol
Similarity: 0.62
[ 69257-04-1 ]
(2S,4S,5R)-1-Benzyl-2-((R)-hydroxy(quinolin-4-yl)methyl)-5-vinylquinuclidin-1-ium chloride
Similarity: 0.86
[ 38092-89-6 ]
8-Chloro-11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
Similarity: 0.56
[ 1231763-32-8 ]
(8α,9S)-6'-Methoxycinchonan-9-amine trihydrochloride
Similarity: 0.56
[ 586966-54-3 ]
tert-Butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
Similarity: 0.53
[ 201594-84-5 ]
(S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine
Similarity: 0.66
[ 122368-54-1 ]
2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine
Similarity: 0.66
[ 210095-58-2 ]
(S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine (2R,3R)-2,3-dihydroxysuccinate
Similarity: 0.59
[ 58-73-1 ]
2-(Benzhydryloxy)-N,N-dimethylethanamine
Similarity: 0.58
[ 69257-04-1 ]
(2S,4S,5R)-1-Benzyl-2-((R)-hydroxy(quinolin-4-yl)methyl)-5-vinylquinuclidin-1-ium chloride
Similarity: 0.86
[ 1231763-32-8 ]
(8α,9S)-6'-Methoxycinchonan-9-amine trihydrochloride
Similarity: 0.56
[ 69257-04-1 ]
(2S,4S,5R)-1-Benzyl-2-((R)-hydroxy(quinolin-4-yl)methyl)-5-vinylquinuclidin-1-ium chloride
Similarity: 0.86
[ 1231763-32-8 ]
(8α,9S)-6'-Methoxycinchonan-9-amine trihydrochloride
Similarity: 0.56